Skip to content

Can Dance Therapy Improve Motor Learning in Parkinson's Disease (PD)?

Can Dance Therapy Improve Motor Learning in Parkinson's Disease?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03549793
Enrollment
100
Registered
2018-06-08
Start date
2017-04-01
Completion date
2018-06-30
Last updated
2018-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

In order to find the most effective rehabilitative therapies for Parkinsonian patients, the present study is aimed to evaluate whether, in a multidisciplinary intensive rehabilitation treatment, the dance therapy, applied to the motor learning, promote additional benefits.

Interventions

BEHAVIORALDance Therapy

the intervention is aimed to ameliorate, through dancing, crucial motor symptoms in PD patients, as walking, balance, postural changes and arm swing

BEHAVIORALexercises without dance

the intervention consists of exercises aimed at training the walking, the balance, the postural changes and the arm swing

Sponsors

Ospedale Generale Di Zona Moriggia-Pelascini
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

The investigator are neurologists, blinded to the treatment received by the patient

Intervention model description

Participants are randomly assigned to experimental group or control group. Both of the groups undergo a rehabilitation treatment. The experimental group undergoes 4-week MIRT (Multidisciplinary Intensive Rehabilitation Treatment) + dance therapy. The control group undergoes 4-week MIRT (Multidisciplinary Intensive Rehabilitation Treatment) + exercises

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Stage 2.5-3 according to the Hoehn and Yahr scale (H&Y); * Stable pharmacological treatment for the last 6 weeks before the enrolment and during the hospitalization;

Exclusion criteria

* Any focal brain lesion detected in brain imaging studies (CT or MRI) performed in the previous 12 months; * Drug-induced dyskinesias; * Disturbing resting and/or action tremor, corresponding to scores 2-4 in the specific items of UPDRS III; * Behavioral disturbances (evaluated with Neuropsychiatric Inventory); * Visual and auditory dysfunctions according to the general clinical evaluation and medical history; * cognitive decline (MMSE correct score \< 24)

Design outcomes

Primary

MeasureTime frameDescription
Timed Up and Go Test (TUG)4 weeksTo determine fall risk and measure the progress of balance, sit to stand, and walking.

Secondary

MeasureTime frameDescription
6 Minutes Walking Test (6MWT)4 weeksThe 6MWT measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes.
Balance Berg Scale (BBS)4 weeksto objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks.

Other

MeasureTime frameDescription
delayed recall of items4 weeksnumber of specific items correctly performed in recall phase

Countries

Italy

Contacts

Primary ContactPaola Ortelli, PsyD
ortellipaola73@gmail.com3332974872

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026